Navigation Links
New York State Approves the Quest Diagnostics ColoVantage™ Colorectal Cancer Blood Test
Date:3/17/2011

of blood taken from a patient's arm. The Septin9 biomarker has shown consistently high performance in colorectal cancer detection in several case-control studies. The biomarker was licensed to Quest Diagnostics by its owner Epigenomics AG (Frankfurt, Prime Standard: ECX), a cancer molecular diagnostics company, in 2008.

In a clinical validation study, ColoVantage correctly identified colorectal cancer in 70 percent of samples of people diagnosed with the cancer. It also correctly detected the absence of colorectal cancer in about 89 percent of samples tested.

"ColoVantage cannot replace colonoscopy, and it has yet to be validated for colon cancer screening," said Jay G. Wohlgemuth, M.D., vice president, science and innovation, Quest Diagnostics. "But the test's ability to detect this cancer may persuade nonadherent screening-eligible individuals who receive a positive result to undergo colonoscopy or other evaluation."

Quest Diagnostics was the first laboratory in the United States to offer a molecular test employing blood taken from a patient's arm for aiding in the detection of colorectal cancer when it released ColoVantage in December 2009. New York is the only U.S. state with an independent regulatory review process for laboratory developed tests, which are also regulated at the federal level. With the approval, Quest Diagnostics can offer ColoVantage in New York as well as in all other U.S. states.

Colorectal cancer is the third most common cancer in men and women in the U.S., with more than 51,000 deaths expected this year, according to estimates from ACS.

About Quest Diagnostics and its Commitment to Colorectal Cancer Testing Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software
2. Dendreon Initiates Second of Two New Phase 2 Trials of PROVENGE for Prostate Cancer
3. Baxter Announces Licensing Agreement for Innocolls Gentamicin Surgical Implant in the United States
4. States First Single Incision Robotic Kidney Removal Performed at Henry Ford Hospital
5. InVitria Further Strengthens Sales Team with Promotion of Brandy Sargent to Account Manager - Western United States
6. Revolutionary New In-Office EVOLVE(R) Laser Prostate Treatment Available Throughout Western Oregon
7. Orange Coast Urology Offers Advanced In-Office Patient EVOLVE(R) Laser Prostate Treatment
8. Department of Justice Provides States With Funding for Testing in Postconviction Cases
9. NC State engineers discover nanoparticles can break on through
10. JD Technologies, LLC Selected by FCT Ingenieurkeramik GmbH to Represent Their High Performance Ceramic Expertise In the United States
11. Exposure to Agent Orange linked to prostate cancer in Vietnam veterans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 2014  PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ... Ernst & Young LLP ("EY") that it was resigning effective ... delivered to the Company on September 15, 2014 and reported ... PDL has issued the following statement in response ... of inquiries on the reason for the resignation of EY.  ...
(Date:9/17/2014)... -- The global consumption of squalene / squalane is expected ... skin-identical chemical that finds applications in various end user industries ... in other applications like high grade lubrication, and fiber coating ... players and is regionally segregated. Sophim ( France ... ( Japan ), SeaDragon Marine Oils Ltd. ( ...
(Date:9/17/2014)... TRIANGLE PARK, N.C. , Sept. 17, 2014 /PRNewswire/ ... and presentation topics that will be featured at the ... Hamner Conference Center on December 3 and 4, 2014. ... managers are invited to hear the following: ... PhD UC San Diego Skaggs School of ...
(Date:9/17/2014)... Shimadzu Scientific Instruments introduces ... which offers a powerful separation method for ... provides a new level of knowledge and ... to scientists analyzing pharmaceutical impurities, proteins, lipids, ... Comprehensive 2D-LC combines two independent separation modes ...
Breaking Biology Technology:PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors 2PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors 3Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 2Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 3In Silico Drug Discovery Conference Announces Speakers and Topics 2In Silico Drug Discovery Conference Announces Speakers and Topics 3In Silico Drug Discovery Conference Announces Speakers and Topics 4In Silico Drug Discovery Conference Announces Speakers and Topics 5In Silico Drug Discovery Conference Announces Speakers and Topics 6In Silico Drug Discovery Conference Announces Speakers and Topics 7Shimadzu’s New Nexera-e Two Dimensional Comprehensive Liquid Chromatograph Empowers Laboratories to Separate Even the Most Complex Mixtures 2
... 26 Amedica Corporation, an,orthopedic implants company focused ... U.S. Food and Drug Administration,has granted 510(k) marketing ... Valeo Pedicle Screw system is a low profile ... aimed at allowing surgeons,greater flexibility in the positioning ...
... (Nasdaq: GNTA ) announced today that the ... Warrell, Jr., will provide a,company overview and update ... Annual Healthcare Conference. Genta,s presentation is scheduled,for Wednesday, ... New York Palace Hotel,New York, NY., The ...
... International Limited, a UK,private company, announces MHRA ... based Phase IIB trial of AIMSPRO(R), its ... cross-over study will seek to,detect a beneficial ... Secondary,Progressive Multiple Sclerosis, following open-label observations over,several ...
Cached Biology Technology:Amedica Receives FDA 510(k) Clearance for Valeo(TM) Pedicle Screw System 2Genta Incorporated to Present at Lazard Capital Markets 4th Annual Healthcare Conference 2Genta Incorporated to Present at Lazard Capital Markets 4th Annual Healthcare Conference 3
(Date:9/18/2014)... Sydney, September 18, 2014 Elsevier, a world-leading ... and services, and the Australasian Research Management Society ... young scientists at the 5th Scopus Young Researcher ... held earlier today at the National Convention Centre ... conference, was attended by guests representing Australia,s and ...
(Date:9/18/2014)... lives nestling in the protective tentacles of host anemones, ... travel hundreds of kilometres across the open ocean. Although ... been predicted, this is the first time that the ... been observed. , Dr Steve Simpson, Senior Lecturer in ... Exeter, and colleagues from the Australian Research Council Centre ...
(Date:9/17/2014)... 2000 as an EC-FP5 four-year project, delivering its first ... and successful participations in several EC projects, as a ... project (EU BON), to increase the general awareness ... extend the general dissemination of the Fauna Europaea results, ... applied its novel e-Publishing tools to prepare data papers ...
Breaking Biology News(10 mins):Elsevier and Australasian Research Management Society award scientists at Scopus ceremony 2Expedition finds Nemo can travel great distances to connect populations 2Expedition finds Nemo can travel great distances to connect populations 3Contributions on Fauna Europaea: Data papers as innovative model on expert involvement 2
... Md. Scientists have provided new details about how ... the blood cells needed for blood clotting. Katsue Suzuki-Inoue, ... Japan, and colleagues have identified for the first time ... a key role in cancer-induced platelet aggregation. These results ...
... the malaria mosquito uses to zero in on its ... an important step toward developing new and improved repellants ... threat of malaria, generally considered the most prevalent life-threatening ... maxillary palp. It is one of three structures extending ...
... has been developed at the Hebrew University Faculty of ... doctoral research at the university, Dr. Orit Bossi succeeded ... process by countering the breakdown of collagen fibers in ... supervision of Zecharia Madar, the Karl Bach Professor ...
Cached Biology News:How cancer spreads by aggregating platelets 2How cancer spreads by aggregating platelets 3Advance in effort to fight malaria by tricking the mosquito's sense of smell 2Advance in effort to fight malaria by tricking the mosquito's sense of smell 3Antioxidant to retard wrinkles discovered by Hebrew University researcher 2
The external laser upgrade for the Molecular Imager FX adds a 635 nm external laser; the 555 nm long pass filter is replaced with a 605 nm band pass filter to distinguish Cy5 from 532 nm excitable dy...
... DNA Kit is designed for fast and ... plant cells and tissues. The bead beating ... DNA isolation procedures such as CTAB, phenol, ... alcohol precipitation is not necessary - purified ...
The filter 530DF28 for the Molecular Imager FX is a band pass filter for ECL Plus, AttoPhos, SYBR Green, Alexa Fluor 488, FITC, Cy2, and Pro-Q Emerald dyes....
... is a single-step staining method for labeling ... flow cytometry. The kit contains all the ... cells including: positive and negative control cells ... rinsing buffers for processing individual steps in ...
Biology Products: